These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 5787285)

  • 61. Peripheral vasodilators versus pentoxifylline for the treatment of intermittent claudication.
    Aviado DM
    Ric Clin Lab; 1983; 13 Suppl 3():263-8. PubMed ID: 6143383
    [TBL] [Abstract][Full Text] [Related]  

  • 62. ["Responders and non-responders" to PGE1 and alpha-cyclodextrin].
    De Sanctis MT; Incandela L; Iacobitti P
    Minerva Cardioangiol; 1998 Oct; 46(10 Suppl 1):31-6. PubMed ID: 10658442
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Practical impact of hemorheology on the treatment of chronic peripheral ischemia.
    Dormandy JA
    Angiology; 1981 Oct; 32(10):710-4. PubMed ID: 7325406
    [No Abstract]   [Full Text] [Related]  

  • 64. Local application of thymoxamine in peripheral vascular disease.
    Turner P; Harrison J; Schoenfeldt R
    Lancet; 1969 Jun; 1(7608):1238-9. PubMed ID: 4182414
    [No Abstract]   [Full Text] [Related]  

  • 65. Inositol nicotinate in intermittent claudication.
    Practitioner; 1986 Jun; 230(1416):506-9. PubMed ID: 3748967
    [No Abstract]   [Full Text] [Related]  

  • 66. Treatment of severe Raynaud's phenomenon and ischemic ulcerations with tissue plasimogen activator.
    Lakshminarayanan S; Vázquez-Abad D; Maestrello SJ; Waterman JR
    Clin Exp Rheumatol; 1999; 17(2):260. PubMed ID: 10342058
    [No Abstract]   [Full Text] [Related]  

  • 67. [Beta-blocking drugs in coronary insufficiency. Clinical experiences with iproveratril].
    Guadagno L; Giannelli G; Ghiara F; Guadagno P; Zucchelli GP
    Minerva Med; 1967 Sep; 58(77):3288-94. PubMed ID: 6054782
    [No Abstract]   [Full Text] [Related]  

  • 68. Sildenafil as a therapeutic option for digital ischemic ulceration: case report.
    Krähenbühl SM; Depairon M; Faure M; Vietti Violi N; Applegate LA; Raffoul W
    J Hand Surg Am; 2015 May; 40(5):890-3. PubMed ID: 25817752
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Microcirculation in peripheral arterial occlusive diseases will improve. Prostaglandin can prevent surgery].
    MMW Fortschr Med; 2003 Dec; 145(51-52):41. PubMed ID: 14974333
    [No Abstract]   [Full Text] [Related]  

  • 70. [Therapy of peripheral arterial circulation disorders using 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191)].
    Denck H
    Arzneimittelforschung; 1973 Apr; 23(4):571-3. PubMed ID: 4740236
    [No Abstract]   [Full Text] [Related]  

  • 71. Severe vasospasm following ergot administration.
    Robb LG
    West J Med; 1975 Sep; 123(3):231-5. PubMed ID: 1162985
    [No Abstract]   [Full Text] [Related]  

  • 72. [Vasoactive agents and prostanoids in the therapy of PAD: facts, questions, disproven assumptions].
    Heidrich H
    Hamostaseologie; 2006 Aug; 26(3):220-3. PubMed ID: 16906239
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Arterial insufficiency in the lower extremities treated with drugs].
    Genster HG; Oram V
    Ugeskr Laeger; 1971 Feb; 133(6):244-6. PubMed ID: 4926100
    [No Abstract]   [Full Text] [Related]  

  • 74. Prostaglandin therapy of peripheral occlusive arterial disease.
    Linhart J
    Sb Lek; 1998; 99(4):355-62. PubMed ID: 10803275
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Treatment of peripheral and cerebral circulation disorders. Experiences with bencyclan-hydrogenfumarate (Fludilat)].
    Frercks J
    Munch Med Wochenschr; 1971 Oct; 113(40):1293-8. PubMed ID: 5171108
    [No Abstract]   [Full Text] [Related]  

  • 76. [Experiences with new Cosaldon forms].
    Dammann C
    Med Klin; 1969 Feb; 64(8):344-8. PubMed ID: 5783023
    [No Abstract]   [Full Text] [Related]  

  • 77. A new study demonstrates the efficacy of naftidrofuryl in the treatment of intermittent claudication. Findings of the Naftidrofuryl Clinical Ischemia Study (NCIS).
    Kieffer E; Bahnini A; Mouren X; Gamand S
    Int Angiol; 2001 Mar; 20(1):58-65. PubMed ID: 11342997
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Effect of buflomedil on microcirculation of the skin in acral gangrene].
    Fagrell B; Hermansson IL
    Fortschr Med; 1985 Jan; 103(1-2):23-7. PubMed ID: 3882535
    [No Abstract]   [Full Text] [Related]  

  • 79. [Tolerance and therapeutic results of iloprost in obliterative arteriopathy in lower limbs at the severe chronic ischemia stage. A retrospective study of 29 consecutive cases].
    Duthois S; Cailleux N; Lévesque H
    J Mal Vasc; 2000 Feb; 25(1):17-26. PubMed ID: 10705132
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [The vasoprostan treatment of patients with Raynaud's syndrome].
    Alekperov RT; Mach ES; Guseva NG
    Ter Arkh; 1997; 69(8):22-3. PubMed ID: 9381386
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.